Suppr超能文献

一名6岁患者因新型甲状腺球蛋白基因变异(Gly145Glu)导致细胞内甲状腺球蛋白转运障碍而出现甲状腺肿大:甲状腺肿大小与游离T3与游离T4比值之间的相关性。

Goiter in a 6-year-old patient with novel thyroglobulin gene variant (Gly145Glu) causing intracellular thyroglobulin transport disorder: Correlation between goiter size and the free T3 to free T4 ratio.

作者信息

Matsuyama Misayo, Sawada Hirotake, Inoue Shinobu, Hishinuma Akira, Sekiya Ryo, Sato Yuichiro, Moritake Hiroshi

机构信息

Division of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.

Department of Fundamental Nursing, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.

出版信息

Clin Pediatr Endocrinol. 2022;31(3):185-191. doi: 10.1297/cpe.2022-0006. Epub 2022 May 16.

Abstract

Thyroglobulin gene abnormalities cause thyroid dyshormonogenesis. A 6-yr-old boy of consanguineous parents presented with a large goiter and mild hypothyroidism (thyroid-stimulating hormone [TSH] 7.2 μIU/mL, free T3 [FT3] 3.4 pg/mL, free T4 [FT4] 0.6 ng/dL). Despite levothyroxine (LT4) administration and normal TSH levels, the goiter progressed slowly and increased rapidly in size at the onset of puberty. Thyroid scintigraphy revealed a remarkably high I uptake of 75.2%, with a serum thyroglobulin level of 13 ng/ml, which was disproportionately low for the goiter size. DNA sequencing revealed a novel homozygous missense variant, c.434G>A [p.Gly145Glu], in the thyroglobulin gene. Goiter growth was suppressed by increasing the LT4 dose. Thyroidectomy was performed at 17-yr-of-age. Thyroglobulin analysis of the thyroid tissue detected mutant thyroglobulin present in the endoplasmic reticulum, demonstrating that thyroglobulin transport from the endoplasmic reticulum to the Golgi apparatus was impaired by the Gly145Glu variant. During the clinical course, an elevated FT3/FT4 ratio was observed along with thyroid enlargement. A high FT3/FT4 ratio and goiter seemed to be compensatory responses to impaired hormone synthesis. Thyroglobulin defects with goiter should be treated with LT4, even if TSH levels are normal.

摘要

甲状腺球蛋白基因异常会导致甲状腺激素合成障碍。一名父母近亲结婚的6岁男孩出现巨大甲状腺肿和轻度甲状腺功能减退(促甲状腺激素[TSH] 7.2 μIU/mL,游离T3[FT3] 3.4 pg/mL,游离T4[FT4] 0.6 ng/dL)。尽管给予了左甲状腺素(LT4)治疗且TSH水平正常,但甲状腺肿仍缓慢进展,并在青春期开始时迅速增大。甲状腺闪烁显像显示碘摄取率显著升高,达75.2%,血清甲状腺球蛋白水平为13 ng/ml,相对于甲状腺肿大小而言该水平不成比例地低。DNA测序显示甲状腺球蛋白基因存在一种新的纯合错义变异,c.434G>A [p.Gly145Glu]。通过增加LT4剂量,甲状腺肿的生长得到抑制。该男孩17岁时接受了甲状腺切除术。对甲状腺组织进行的甲状腺球蛋白分析检测到在内质网中存在突变的甲状腺球蛋白,表明Gly145Glu变异损害了甲状腺球蛋白从内质网向高尔基体的转运。在临床过程中,观察到随着甲状腺肿大,FT3/FT4比值升高。高FT3/FT4比值和甲状腺肿似乎是对激素合成受损的代偿反应。即使TSH水平正常,伴有甲状腺肿的甲状腺球蛋白缺陷也应用LT4治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a298/9297170/ed97317b6311/cpe-31-185-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验